Previous Close | 6.85 |
Open | 6.85 |
Bid | 6.89 x 300 |
Ask | 6.91 x 100 |
Day's Range | 6.82 - 6.97 |
52 Week Range | 1.96 - 6.97 |
Volume | |
Avg. Volume | 1,651,090 |
Market Cap | 2.131B |
Beta (5Y Monthly) | 1.34 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
BRIDGEWATER, N.J., May 03, 2024--AMNEAL REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
BRIDGEWATER, N.J., April 24, 2024--Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
BRIDGEWATER, N.J., April 16, 2024--Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine